» Articles » PMID: 33962695

Neurological Pathogenesis of SARS-CoV-2 (COVID-19): from Virological Features to Clinical Symptoms

Overview
Journal Inflamm Regen
Publisher Biomed Central
Date 2021 May 8
PMID 33962695
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Since the worldwide outbreak of coronavirus disease 2019 (COVID-19) in 2020, various research reports and case reports have been published. It has been found that COVID-19 causes not only respiratory disorders but also thrombosis and gastrointestinal disorders, central nervous system (CNS) disorders, and peripheral neuropathy. Compared to other disorders, there are low number of research reports and low number of summaries on COVID-19-related neural disorders. Therefore, focusing on neural disorders, we outline both basic research and clinical manifestations of COVID-19-related neural disorders.

Citing Articles

Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine Used.

Gobel C, Heinze A, Heinze-Kuhn K, Karstedt S, Morscheck M, Tashiro L Vaccines (Basel). 2025; 13(2).

PMID: 40006661 PMC: 11861871. DOI: 10.3390/vaccines13020113.


Independent Risk Factors and Mortality Implications of De Novo Central Nervous System Involvement in Patients Hospitalized with Severe COVID-19: A Retrospective Cohort Study.

Hanganu A, Dulamea A, Niculae C, Moisa E, Hristea A J Clin Med. 2024; 13(13).

PMID: 38999510 PMC: 11242379. DOI: 10.3390/jcm13133948.


Complexity and Diversity of the Neurological Spectrum of SARS-CoV-2 over Three Waves of COVID-19.

Jachman-Kapulka J, Zinczuk A, Szymanski W, Simon K, Rorat M J Clin Med. 2024; 13(12).

PMID: 38930003 PMC: 11204600. DOI: 10.3390/jcm13123477.


SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity.

Martinez-Marmol R, Giordano-Santini R, Kaulich E, Cho A, Przybyla M, Riyadh M Sci Adv. 2023; 9(23):eadg2248.

PMID: 37285437 PMC: 10246911. DOI: 10.1126/sciadv.adg2248.


Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy.

Akanchise T, Angelova A Pharmaceutics. 2023; 15(5).

PMID: 37242804 PMC: 10224264. DOI: 10.3390/pharmaceutics15051562.


References
1.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

2.
Hodge R, Bakken T, Miller J, Smith K, Barkan E, Graybuck L . Conserved cell types with divergent features in human versus mouse cortex. Nature. 2019; 573(7772):61-68. PMC: 6919571. DOI: 10.1038/s41586-019-1506-7. View

3.
Arbour N, Day R, Newcombe J, Talbot P . Neuroinvasion by human respiratory coronaviruses. J Virol. 2000; 74(19):8913-21. PMC: 102086. DOI: 10.1128/jvi.74.19.8913-8921.2000. View

4.
Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V . Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect. 2020; 27(3):458-466. PMC: 7661948. DOI: 10.1016/j.cmi.2020.11.005. View

5.
Romero-Sanchez C, Diaz-Maroto I, Fernandez-Diaz E, Sanchez-Larsen A, Layos-Romero A, Garcia-Garcia J . Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020; 95(8):e1060-e1070. PMC: 7668545. DOI: 10.1212/WNL.0000000000009937. View